v3.10.0.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Statement of Comprehensive Income [Abstract]      
Net income before allocation to noncontrolling interests [1],[2],[3],[4] $ 11,188 $ 21,355 $ 7,246
Foreign currency translation adjustments, net [2] (799) 1,116 (815)
Reclassification adjustments [2],[5] (22) 162 0
Other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, total [2] (821) 1,278 (815)
Unrealized holding gains/(losses) on derivative financial instruments, net [2] 220 (10) (442)
Reclassification adjustments for (gains)/losses included in net income(b) [2],[6] 27 (520) 452
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total [2] 247 (530) 10
Unrealized holding gains/(losses) on available-for-sale securities, net [2] (185) 818 248
Reclassification adjustments for (gains)/losses included in net income [2],[6] 124 (244) (118)
Reclassification adjustments for unrealized gains included in Retained earnings [2],[7] (462) 0 0
Other comprehensive income (loss), available-for-sale securities adjustment, before tax, total [2] (522) 574 130
Benefit plans: actuarial losses, net [2] (649) (212) (1,888)
Reclassification adjustments related to amortization [2] 242 588 558 [7]
Reclassification adjustments related to settlements, net [2] 142 117 127 [7]
Other [2] 112 (145) 195
Defined benefit Plan, amounts recognized in other comprehensive income (loss), net gain (loss), before tax, total [2] (153) 348 (1,009)
Benefit plans: prior service (costs)/credits and other, net [2] (9) (2) 184
Reclassification adjustments related to amortization [2] (181) (184) (173) [7]
Reclassification adjustments related to curtailments, net [2] (19) (18) (26) [7]
Other [2] 2 0 6
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax [2] (207) (203) (8)
Other comprehensive income/(loss), before tax [2] (1,457) 1,468 (1,692)
Tax provision/(benefit) on other comprehensive income/(loss) [2],[8] 518 (262) (174)
Other comprehensive income/(loss) before allocation to noncontrolling interests [2],[4] (1,975) 1,730 (1,518)
Comprehensive income before allocation to noncontrolling interests [2] 9,214 23,085 5,728
Less: Comprehensive income attributable to noncontrolling interests [2] 16 62 28
Comprehensive income attributable to Pfizer Inc. [2] $ 9,198 $ 23,023 $ 5,701
[1] Amounts may not add due to rounding.
[2] Amounts may not add due to rounding.
[3] Amounts may not add due to rounding.
[4] Amounts may not add due to rounding.
[5] For the year ended December 31, 2017, the foreign currency translation adjustments reclassified into Other (income)/deductions—net in the consolidated statement of income primarily result from the sale of our 40% ownership investment in Teuto and the sale of our 49% equity share in Hisun Pfizer. See Note 2F. Acquisitions, Divestitures, Assets and Liabilities Held for Sale, Licensing Arrangements, Research and Development and Collaborative Arrangements, Equity-Method Investments and Privately Held Investment: Equity-Method Investments.
[6] Reclassified into Other (income)/deductions—net and Cost of sales in the consolidated statements of income. For additional information on amounts reclassified into Cost of sales, see Note 7F. Financial Instruments: Derivative Financial Instruments and Hedging Activities.
[7] For additional information, see Note 1B. Basis of Presentation and Significant Accounting Policies: Adoption of New Accounting Standards in 2018.
[8] See Note 5E. Tax Matters: Tax Provision/(Benefit) on Other Comprehensive Income/(Loss).